Red Flags for Differentiating Desmosomal "Hot-Phase" Cardiomyopathy From Acute Myocarditis
Giovanni Peretto1,2,3, Nicolas Piriou4, Alessio Gasperetti5
1Multidisciplinary Disease Unit for Myocarditis and Arrhythmogenic Cardiomyopathies IRCCS San Raffaele Scientific Institute Milan Italy.
Insights
Desmosomal hot-phase cardiomyopathy (HPC) primarily affects young women and can be distinguished from acute myocarditis (AM) using specific diagnostic red flags. Identifying these markers improves early recognition and patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Desmosomal hot-phase cardiomyopathy (HPC) presents with myocardial inflammation mimicking acute myocarditis (AM).
- HPC carries significant risks of adverse cardiovascular outcomes.
- Distinguishing HPC from AM is crucial for appropriate management.
Purpose of the Study:
- To identify diagnostic red flags that differentiate desmosomal hot-phase cardiomyopathy (HPC) from acute myocarditis (AM).
- To develop and validate diagnostic algorithms for HPC detection.
Main Methods:
- Retrospective analysis of 134 patients with initial AM diagnosis.
- HPC defined by pathogenic desmosomal gene variants (DGVs); controls were gene-negative AM.
- Comparison of clinical, imaging, and electrical features to identify red flags.
- Validation of diagnostic algorithms in an external cohort of DGV carriers.
Main Results:
- HPC patients (22/134) were younger and more frequently female than AM controls.
- Distinctive red flags in DGV carriers included family history, recurrent troponin peaks, ventricular dysfunction/arrhythmias, and specific MRI findings.
- A 'first-contact' algorithm (female sex, age <30) showed 77% accuracy.
- An algorithm using MRI (ring-like LGE, RV involvement) and family history achieved 93% accuracy.
Conclusions:
- Myocarditis in desmosomal gene variant carriers predominantly affects young women.
- A red flag-based diagnostic approach enhances the recognition of desmosomal HPC compared to classic AM.
- Improved diagnostic strategies can lead to better patient management and outcomes.
Background:
Desmosomal "hot-phase" cardiomyopathy (HPC), characterized by bursts of myocardial inflammation mimicking acute myocarditis (AM), carries relevant risks of adverse outcomes. This study aimed to identify diagnostic "red flags" favoring HPC over AM.
Methods:
Patients (n=134) receiving a first diagnosis of AM, proven by endomyocardial biopsy or cardiac magnetic resonance plus troponin elevation, were retrospectively identified at a referral center. HPC was defined by presence of pathogenic desmosomal gene variants (DGVs). Clinical, imaging, and electrical features were compared between HPC cases and controls with gene-negative AM to identify red flags. Diagnostic algorithms were derived and tested in an external multicenter cohort of DGV carriers (n=30).
Results:
Patients with HPC (n=22; 91% DSP+) were more frequently female (73% versus 24%, P<0.001) and younger than unmatched controls with AM (32±14 versus 41±14 years, P=0.007). When matched 1:1 by age, sex, and presentation, DGV carriers showed distinctive red flags: family history of cardiomyopathy/AM/sudden death; recurrent troponin peaks; persistent left ventricular systolic dysfunction; right ventricular involvement; ring-like late gadolinium enhancement; late gadolinium enhancement persistence or extension; low QRS voltages; life-threatening ventricular arrhythmias at <45 years; persistent >1000/24 hours ventricular ectopy; and recurrent nonsustained ventricular tachycardia. A "first-contact" algorithm based on female sex and age <30 years achieved 77% accuracy, identifying 63% of DGV carriers in the external cohort. An alternative algorithm incorporating ring-like late gadolinium enhancement, right ventricular involvement, and family history showed higher accuracy (93%) and yield (93%).
Conclusions:
Myocarditis in DGV carriers predominantly affects young women. A red flag-based approach improves recognition of desmosomal HPC over classic AM.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Desmosomes
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
